Skip to main content
Northwestern University Feinberg School of Medicine

News and Breakthroughs

Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the Lurie Cancer Center news archive.

Visit our gallery to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.

  • 06.14.2024

    Combining two cancer drugs may be a promising treatment for advanced metastatic breast cancer, according to the results of a clinical trial published in the Journal of Clinical Oncology.

  • 06.13.2024

    Northwestern Medicine scientists have discovered that a weakened form of a virus can be used to help eliminate cancer in mice.

  • 06.13.2024

    Thank you for celebrating with us! On Sunday, June 2, our 31st Annual Cancer Survivors’ Celebration Walk & 5K brought together nearly 4,000 cancer survivors and supporters in Grant Park to connect as a community, celebrate milestones, and change the future of cancer care.

  • 06.06.2024

    Northwestern Medicine scientists have used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy and immunotherapy, a major advance for the treatment of this deadly cancer.

  • 05.28.2024

    On Sunday, June 2, Lurie Cancer Center and Northwestern Medicine will welcome cancer survivors and supporters to our 31st Annual Cancer Survivors’ Celebration Walk & 5K!

  • 05.24.2024

    Patients with metastatic urothelial cancer and increased expression of the NECTIN4 gene had a dramatically better response to antibody treatment than patients with reduced gene expression, according to recent findings published in the Journal of Clinical Oncology.

  • 05.23.2024

    Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss leading-edge research in cancer care at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31- June 4 at McCormick Place in Chicago, and Online. Visit us at Booth 13013.

  • 05.17.2024

    Investigators have discovered new mechanisms underlying intratumor heterogeneity and treatment resistance in meningiomas, the most common type of primary central nervous system tumor, according to a recent study published in Nature Genetics.

  • 05.16.2024

    A recent study from the laboratory of Shi-Yuan Cheng, PhD, has identified novel mechanisms underlying RNA splicing events within glioma tumor cells, mechanisms which may serve as novel therapeutic targets, according to findings published in The Journal of Clinical Investigation.

  • 05.09.2024

    Prostate cancer is the most common type of cancer in men and is currently the second-leading cause of death in men in the U.S. In 2001, the National Cancer Institute established seven Specialized Programs of Research Excellence (SPORE) in prostate cancer across the U.S., one of which includes the Robert H. Lurie Comprehensive Cancer Center of Northwestern University’s Prostate Cancer SPORE.

  • 05.08.2024

    New advances in digital pathology are revolutionizing the analysis of disease, paving the way for greater accuracy and efficiency when it comes to diagnostics, predicting outcomes and treatment. In this episode, Lee Cooper, PhD, discusses the future of digital and computational pathology and his research on machine learning and pathology, including a recent study published in Nature Medicine on using AI in predicting clinical outcomes for breast cancer patients.

  • 05.07.2024

    Patients with lung cancer who were Asian/Pacific Islander, Black or Hispanic experienced a higher intensity of end-of-life care compared to white patients, according to a Northwestern Medicine population-based analysis published in the Journal of Clinical Oncology.

  • 05.07.2024

    On May 6, Kristin Smith, Fertility Preservation Patient Navigator at Lurie Cancer Center, shared insights on fertility issues faced by people with cancer as a Keynote Speaker at the National Comprehensive Cancer Network’s (NCCN) Oncology Policy Summit focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.

  • 05.02.2024

    Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a study published in Science Advances.

  • 05.01.2024

    A multiprotein complex is essential for regulating cellular transcription response to oxygen deprivation, a key feature of cancer, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.

  • 04.29.2024

    A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses, according to findings published in the Journal of Clinical Investigation.

  • 04.24.2024

    A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.

  • 04.19.2024

    Women with breast cancer who carried the BRCA1 breast cancer mutation and who were enrolled in an MRI surveillance program saw an 80 percent reduction in breast cancer mortality compared to those who did not undergo MRI surveillance, according to findings published in JAMA Oncology.

  • 04.11.2024

    A Northwestern Medicine study has detailed the development of a machine learning model to predict DNA methylation status in cell-free DNA by its fragmentation patterns, according to findings published in Nature Communications.

  • 04.10.2024

    Northwestern Medicine investigators have discovered that inhibiting a chromatin remodeling complex associated with a particular gene in small-cell lung cancer cells may decrease cancer cell differentiation and tumor growth, according to findings published in Nature Communications.

  • 04.10.2024

    When Kristen Young joined the Harold E. Eisenberg Foundation as Executive Director in 2022, she was inspired by their dedication to advancing breakthrough gastrointestinal cancer research at the Lurie Cancer Center. Just two months later, Kristen was diagnosed with stage 3 colon cancer at the age of 37.

  • 04.08.2024

    A recent Northwestern Medicine study has discovered a previously unknown molecular mechanism that supports antitumor responses and cell survival in cytotoxic immune cells, according to findings published in the Journal of Clinical Investigation.

  • 03.27.2024

    A model can accurately predict the risk of bloodstream infections in a subset of children with cancer, according to a study published in the Journal of Clinical Oncology.

  • 03.26.2024

    Northwestern Medicine investigators have identified a metabolism-related gene that may play a role in recruiting immune cells to support the growth of aggressive brain tumors, according to a study recently published in Nature Communications.

  • 03.20.2024

    Northwestern Medicine investigators led by Amy Heimberger, MD, PhD, have discovered a new mechanism in which cancer-associated fibroblasts are associated with tumor grade and mediate immune suppression in glioma tumors.

  • 03.18.2024

    Two methods of prostate cancer biopsy demonstrated similar, minimal rates of infection in patients with prostate cancer, according to a recent Northwestern Medicine study published in the journal European Urology.

  • 03.13.2024

    Northwestern Medicine scientists have identified new genes implicated in the development of uterine fibroids, according to a study published in Nature Communications.

  • 03.04.2024

    A type of white blood cell is responsible for growth and branching of blood vessels which supports tumor growth in colon cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.

  • 03.04.2024

    The Lynn Sage Breast Cancer Foundation is convening cancer research leaders in a never-been-done-before collaboration that will make clinical trials more accessible to Chicago-area breast cancer patients. The initiative — called the Chicago Breast Cancer Research Consortium — comprised of Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Medicine, University of Chicago Medicine, and RUSH University for Health — is the first-of-its-kind in Chicago and is funded by a $1.8 million donation from the Lynn Sage Breast Cancer Foundation.

See more news in the article archive.